Alnylam Pharmaceuticals ALNY
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 270.02 | 115 | -62.98 | -57 | -1.36 | 4,214 |
| 2024Q4 | 235.31 | 67 | -168.47 | -84 | -1.98 | 4,240 |
| 2024Q3 | 275.03 | 32 | -112 | -2.72 | 4,205 | |
| 2024Q2 | 243.00 | -3 | -17 | -0.43 | 4,010 | |
| 2024Q1 | 149.45 | -219 | -66 | -1.72 | 3,824 | |
| 2023Q4 | 191.41 | -221 | -138 | -3.60 | 3,830 | |
| 2023Q3 | 177.10 | -166 | 148 | 4.08 | 3,839 | |
| 2023Q2 | 189.94 | -408 | -276 | -8.13 | 3,402 | |
| 2023Q1 | 200.32 | -259 | -174 | -5.02 | 3,392 | |
| 2022Q4 | 237.65 | -158 | -207 | -5.86 | 3,546 | |
| 2022Q3 | 200.16 | -68 | -406 | -11.82 | 3,535 | |
| 2022Q2 | 145.85 | 176 | -96.12 | -277 | -8.20 | 3,330 |
| 2022Q1 | 163.29 | 401 | -48.58 | -240 | -6.79 | 3,434 |
| 2021Q4 | 169.58 | 588 | -38.46 | -258 | -7.26 | 3,643 |
| 2021Q3 | 188.81 | 756 | -25.42 | -205 | -5.86 | 3,472 |
| 2021Q2 | 169.52 | 853 | -21.30 | -190 | -5.60 | 3,509 |
| 2021Q1 | 141.19 | 926 | -20.62 | -200 | -6.01 | 3,255 |
| 2020Q4 | 129.97 | 1,016 | -21.83 | -244 | -7.25 | 3,407 |
| 2020Q3 | 145.60 | 1,215 | -19.37 | -253 | -7.58 | 3,307 |
| 2020Q2 | 148.11 | 1,400 | -13.04 | -179 | -6.34 | 3,374 |